Resultados de la búsqueda 391-400 of 14661 for Severe hypertriglyceridaemia
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...
A Study to Evaluate Neurostimulation to Treat Chronic Upper Limb Pain After Brachial Plexus Injury. Rochester, Minn., Jacksonville, Fla. This study is designed ...
... acute kidney injury provides strong predictive ability for AKI and potential therapeutic targets. ... acute kidney injury provides strong predictive ...
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke. Rochester, Minn. The purpose of this study ...
... severe residual upper-extremity motor impairment due to stroke. A Study To Create A Registry Of Non-Fusion Spinal Deformity Correction In Adolescent ...
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...
The primary purpose/objective of this study is to determine whether myectomy as a management option for severe hypertrophic cardiomyopathy (HCM) reduces the ...
Caselli S, et al. Left ventricular hypertrophy in athletes, a case-control analysis of interindividual variability. International Journal of Cardiology.
The purpose of this study is to determine whether patients with ADPKD present with abnormal levels of fumarate that correlates with disease severity and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?